Cargando…

Lead Screening for HIV of C-C Chemokine Receptor Type 5 Receptor Inhibited by Traditional Chinese Medicine

The acquired immunodeficiency syndrome (AIDS), caused by the human immunodeficiency virus (HIV), has become a serious world-wide problem because of this disease's rapid propagation and incurability. Recent research has pointed out that the C-C chemokine receptor type 5 (CCR5) is an important ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hung, Tzu-Chieh, Chen, Kuen-Bao, Huang, Hung-Jin, Chen, Calvin Yu-Chian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021832/ https://www.ncbi.nlm.nih.gov/pubmed/24876870 http://dx.doi.org/10.1155/2014/313094

Ejemplares similares

Lead Screening for CXCR4 of the Human HIV Infection Receptor Inhibited by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Lead Screening for HIV-1 Integrase (IN) Inhibited by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

The Inhibition of Folylpolyglutamate Synthetase (folC) in the Prevention of Drug Resistance in Mycobacterium tuberculosis by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Investigation of Potent Lead for Acquired Immunodeficiency Syndrome from Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Insight into HIV of IFN-Induced Myxovirus Resistance 2 (MX2) Expressed by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

An Investigation of Small GTPases in relation to Liver Tumorigenesis Using Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

In Silico Investigation of Cytochrome P450 2C9 in relation to Aging Using Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Treatment of Cardiovascular Disease by Traditional Chinese Medicine against Pregnane X Receptor
por: Chen, Kuen-Bao, et al.
Publicado: (2014)

In Silico Investigation of Traditional Chinese Medicine Compounds to Inhibit Human Histone Deacetylase 2 for Patients with Alzheimer's Disease
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese Medicine
por: Tsou, Yung-An, et al.
Publicado: (2014)

Possible Inhibitor from Traditional Chinese Medicine for the β Form of Calcium-Dependent Protein Kinase Type II in the Treatment of Major Depressive Disorder
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Design of Glucagon-Like Peptide-1 Receptor Agonist for Diabetes Mellitus from Traditional Chinese Medicine
por: Tang, Hsin-Chieh, et al.
Publicado: (2014)

Lead Discovery for Alzheimer's Disease Related Target Protein RbAp48 from Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

In Silico Investigation of Potential Pyruvate Kinase M2 Regulators from Traditional Chinese Medicine against Cancers
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico
por: Chen, Calvin Yu-Chian
Publicado: (2011)

In Silico Design of BACE1 Inhibitor for Alzheimer's Disease by Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

Potential Retinoid X Receptor Agonists for Treating Alzheimer's Disease from Traditional Chinese Medicine
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

Treatment of Acute Lymphoblastic Leukemia from Traditional Chinese Medicine
por: Hsiao, Ya-Li, et al.
Publicado: (2014)

Pharmacological Chaperone Design for Reducing Risk Factor of Parkinson's Disease from Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

Ligand-Based and Structure-Based Investigation for Alzheimer's Disease from Traditional Chinese Medicine
por: Liao, Kai Hsin, et al.
Publicado: (2014)

Drug Design of Cyclin-Dependent Kinase 2 Inhibitor for Melanoma from Traditional Chinese Medicine
por: Tang, Hsin-Chieh, et al.
Publicado: (2014)

Uroporphyrinogen Decarboxylase as a Potential Target for Specific Components of Traditional Chinese Medicine: A Virtual Screening and Molecular Dynamics Study
por: Tsou, Yung-An, et al.
Publicado: (2012)

Investigation of the Novel Lead of Melanocortin 1 Receptor for Pigmentary Disorders
por: Tang, Hsin-Chieh, et al.
Publicado: (2014)

Computational Design of Apolipoprotein E4 Inhibitors for Alzheimer's Disease Therapy from Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

In Silico Design for Adenosine Monophosphate-Activated Protein Kinase Agonist from Traditional Chinese Medicine for Treatment of Metabolic Syndromes
por: Tang, Hsin-Chieh, et al.
Publicado: (2014)

Treatment of Rheumatoid Arthritis with Traditional Chinese Medicine
por: Lee, Wen-Yuan, et al.
Publicado: (2014)

Two Birds with One Stone? Possible Dual-Targeting H1N1 Inhibitors from Traditional Chinese Medicine
por: Chang, Su-Sen, et al.
Publicado: (2011)

In Silico Investigation of Traditional Chinese Medicine for Potential Lead Compounds as SPG7 Inhibitors against Coronary Artery Disease
por: Chen, Kuen-Bao, et al.
Publicado: (2016)

Finding Inhibitors of Mutant Superoxide Dismutase-1 for Amyotrophic Lateral Sclerosis Therapy from Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

In Silico Identification of Potent PPAR-γ Agonists from Traditional Chinese Medicine: A Bioactivity Prediction, Virtual Screening, and Molecular Dynamics Study
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

In Silico Investigation of Potential Src Kinase Ligands from Traditional Chinese Medicine
por: Tou, Weng Ieong, et al.
Publicado: (2012)

When Modern Technology Meets Ancient Traditional Chinese Medicine
por: Chen, Calvin Yu-Chian, et al.
Publicado: (2015)

Identification of tyrosinase inhibitors from traditional Chinese medicines for the management of hyperpigmentation
por: Tang, Hsin-Chieh, et al.
Publicado: (2015)

The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine
por: Beck, Tyler C., et al.
Publicado: (2020)

In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

In Silico Identification of Potent Pancreatic Triacylglycerol Lipase Inhibitors from Traditional Chinese Medicine
por: Chen, Kuan-Yu, et al.
Publicado: (2012)

Potential Protein Phosphatase 2A Agents from Traditional Chinese Medicine against Cancer
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

Drug Design for Neuropathic Pain Regulation from Traditional Chinese Medicine
por: Tou, Weng Ieong, et al.
Publicado: (2013)

C-C Chemokine Receptor 7 in Cancer
por: Bill, Colin A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c5tasq22ishp3ds507dnivt5hq